August 18, 2025 Merck’s Enflonsia™ now part of the CPP portfolio 0 By cpp@nationwidechildrens.org ACIP Discount RSV Vaccine Management We’re excited to share that Merck’s new monoclonal antibody, Enflonsia™, is now part of the CPP portfolio. This addition reflects the…
